Provided by Tiger Trade Technology Pte. Ltd.

MDxHealth, Inc.

3.53
+0.13003.82%
Volume:82.17K
Turnover:287.49K
Market Cap:181.32M
PE:-5.53
High:3.59
Open:3.56
Low:3.40
Close:3.40
52wk High:5.33
52wk Low:1.35
Shares:51.36M
Float Shares:35.02M
Volume Ratio:0.73
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6388
EPS(LYR):-1.1585
ROE:-720.01%
ROA:-5.52%
PB:-21.94
PE(LYR):-3.05

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Fulcrum Therapeutics (FULC), Teladoc (TDOC) and MDxHealth (MDXH)

TIPRANKS
·
Jan 13

Lake Street Sticks to Their Buy Rating for MDxHealth (MDXH)

TIPRANKS
·
Jan 13

MDxHealth Sa - Issues 2026 Revenue Guidance of $137-$140 Mln

THOMSON REUTERS
·
Jan 12

MDxHealth Sa: Expects to Report Q4 REV About $30.5 Mln

THOMSON REUTERS
·
Jan 12

Press Release: MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

Dow Jones
·
Jan 12

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

GlobeNewswire
·
Jan 06

MDxHealth Files to Sell Up to $200 Million in Shares

MT Newswires Live
·
Dec 30, 2025

BRIEF-MDxHealth SA - To Offer Securities Up To $200 Million - SEC Filing

Reuters
·
Dec 30, 2025

MDxHealth Sa - to Offer Securities up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Dec 30, 2025

MDxHealth Price Target Maintained With a $7.00/Share by BTIG

Dow Jones
·
Dec 23, 2025

MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Simply Wall St.
·
Dec 02, 2025

MDxHealth price target raised to $7 from $5 at TD Cowen

TIPRANKS
·
Nov 13, 2025

MDxHealth (MDXH) Receives a Buy from BTIG

TIPRANKS
·
Nov 13, 2025

MDxHealth Is Maintained at Buy by BTIG

Dow Jones
·
Nov 13, 2025

Positive Outlook for MDxHealth: Strategic Moves and Undervalued Growth Potential Reinforce Buy Rating

TIPRANKS
·
Nov 13, 2025

Mdxhealth S.A. Reports Strong Q3 Growth and Strategic Acquisition

TIPRANKS
·
Nov 13, 2025

Positive Outlook for MDxHealth: Strategic Acquisition and Focus on High-Return Products Drive Growth Potential

TIPRANKS
·
Nov 13, 2025

MDxHealth sees FY25 revenue $108M-$110M, consensus $94.05M

TIPRANKS
·
Nov 13, 2025

MDxHealth Q3 EPS $(0.16) Misses $(0.11) Estimate, Sales $27.433M Miss $28.126M Estimate

Benzinga
·
Nov 13, 2025

MDxHealth Sa: Q3 Revenue of $27.4 Mln, Loss per Share $0.16

THOMSON REUTERS
·
Nov 13, 2025